/Investor DB

Optum Ventures — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Nema HealthinOct 2024SEC filingmedium confidence

HealthtechBranford, US

Sofia Noori(Executive Officer, Director)Mariam Malik(Executive Officer)in

BoardAdrienne Rosenthal(Director)

Board seatLaura Veroneau· per SEC Form D · $14.5M raise · filed Nov 2024

Co-investors.406 VenturesDeerfield Management Company

Calibratecalibratevc.comin𝕏Feb 2024 · $100M

Calibrate Ventures is a seed-stage venture capital firm that invests in startups working on AI, automation, autonomy, machine learning, and robotics, partnering with technical founders at the earliest stages.

AI & Machine LearningDeep TechRobotics

Kevin Dunlap(Co-Founder & Managing Partner)inJason Schoettler(Co-Founder & Managing Partner)in

Co-investorsFoundryFounders FundRedesign HealthThreshold VenturesTiger Global Management

Calibratejoincalibrate.com𝕏Feb 2024 · $100M

Calibrate offers a Metabolic Reset weight-loss program that combines GLP-1 medications prescribed by clinicians with lifestyle coaching to help members lose weight and maintain it.

Digital HealthHealthtechWellness & Fitness

Isabelle Kenyon(Founder)

Co-investorsDeclaration PartnersGaingelsGeneral MillsPLUS CapitalSamsung NextThreshold Ventures+4 more

Humata Healthhumatahealth.comin𝕏May 2024

Humata provides an end-to-end platform to streamline prior authorization processes in healthcare, reducing delays and improving care access for patients.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMiami, US

Jeremy Friese(Founder, MD)inOscar Callejas(Executive Officer)inMichael Kolb(Executive Officer)inPhilip Fibiger(Executive Officer)in

BoardWord D. Peake(Director)Thomas Hawes(Director)in

Co-investors.406 VenturesBlue Venture FundsLRVHealthOSF Ventures

Synapticuresynapticure.comin𝕏Sep 2024 · $25M

Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.

AI & Machine LearningDigital HealthHealthtechChicago, US

Peter Wallach(Founding CEO, Founder)Brian Wallach(Founder)inMartina de Majo(Founder)inSandra Abrevaya(Co-Founder, Chief Executive Officer)inJason Langheier(Co-Founder, Board Co-Chair)inJaimie Hatcher-Martin(Dr.)

Co-investorsGeneral AtlanticSV AngelB Capital GroupB4 CapitalBeaconsfield CapitalCVS Health Ventures+15 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.